Google, AHA create a $50M heart drug collaboration

Google Life Sciences ($GOOG) joined the American Heart Association in creating a new $50 million research initiative to find better heart drugs. The groups hope that a multidisciplinary approach to research can do a better job in discovering new cardio therapies, which remains a major challenge as biotechs assess the cost of developing new heart remedies. Story

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

While the biotech IPO market booms, it can look like going public is easy. But the right strategy, syndicate and aftermarket are still important.

Gene therapy pioneer Jim Wilson and the University of Pennsylvania are teaming up with Regeneron to help deliver its COVID antibody intransally.

Forty percent of PK deficiency patients on mitapivat had hemoglobalin responses, compared to 0% in the placebo group.